- Home
- NATR vs LYEL Comparison
NATR vs LYEL Comparison
Compare NATR & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | LYEL |
|---|---|---|
| Founded | 1972 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.3M | 490.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NATR | LYEL |
|---|---|---|
| Price | $25.77 | $21.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $21.33 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 108.1K | 95.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $454,364,000.00 | $61,000.00 |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $32.86 | ★ N/A |
| Revenue Growth | ★ 2.03 | N/A |
| 52 Week Low | $11.01 | $0.39 |
| 52 Week High | $28.14 | $45.00 |
Technical Indicators
Market Signals| Indicator | NATR | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 41.25 |
| Support Level | $13.69 | $21.27 |
| Resistance Level | $26.96 | $27.30 |
| Average True Range (ATR) | 0.92 | 2.12 |
| MACD | -0.21 | 0.04 |
| Stochastic Oscillator | 12.50 | 23.84 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.